Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor ?/? agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples